Biotechnology (Microbiology, CAR-T, Upstream Manufacturing of Biosimilars, R & D in IVD kits) professional with 6 years of experience as a researcher. Extensive experience with cGMP,GLP, Aseptic laboratory techniques and equipment. Exceptional organizational and problem-solving skills.
Overview
7
7
years of professional experience
Work History
Research Associate
Institute for Life Sciences Entrepreneurship (ILSE)
, USA
04.2018 - 07.2019
Executed DNA extraction, quantification, sample incubation, and cryopreservation
Managed the archiving and upkeep of a diverse library of over 300 microbial strains, including bacteria, yeast, actinomycetes, and fungi
Generated and reported NanoDrop and Qubit findings; regularly conducted PCR, restriction digestion, and gel electrophoresis
Conducted MIC and MBC assays on 100+ strains to evaluate antibiotic effects, utilizing 96-well plate assays, and carried out synergy tests
Investigated spontaneous resistance in gram-positive bacteria to target antibiotics
Proficiently operated within an anaerobic chamber AS-580 environment
Cultivated and cryopreserved 250+ microbial strains post-log phase confirmation
Determined CFU using optical density measurements and dilution plating techniques
Executed chemical inactivation of bacteria, ensuring the preservation of cellular structure and DNA
Verified cellular integrity post-inactivation via cell imaging and flow cytometry
Authored SOPs and work instructions tailored to specific bacterial strains
Applied CRISPR/Cas9 technology for the targeted genetic editing of selected organisms
Performed a study on spontaneous resistance to identify how often and through what mechanisms gram-positive bacteria develop reduced susceptibility to a specific antibiotic
Sr. Research Associate
Institute for Life Sciences Entrepreneurship (ILSE)
, USA
08.2019 - 12.2019
Managed and executed multiple projects autonomously, utilizing advanced microbiological and molecular laboratory techniques
Contributed technical and scientific expertise to research leadership
CAR-T Scientist
Eurofins PSS (Client: Johnson & Johnson)
, USA
01.2020 - 08.2021
Conducted NK and Daudi Cell Line Maintenance
Sample Testing
Utilized Viral Copy number, vesicular stomatitis virus G protein (DNA Isolation and qPCR using quant studio 6) for detecting presence and amount of Lentiviral (Transforming agent) DNA in the patient CAR-T cells
NC200 cell counter for cell count and viability of the patient cells
Beckman Coulter Lyric flow cytometry (3C, 5C, 8C) for patient sample analysis of cell groups
Analyzed results and documented data in the Electronic Lab Notebook (ELN-BIOVIA)
Executed Tumor Killing Assays (using microplate based luminous assay machine-Spectra max L) to evaluate the efficacy of CAR-T drug products
Trained and supervised new lab personnel in standard procedures and techniques
Upstream Manufacturing Scientist
Unicon Pharma (Client: Kashiv BioSciences)
, USA
08.2022 - 05.2023
Oversaw the culture and expansion of CHO cell line, adhering to set protocols and production schedules
Maintained aseptic conditions and upheld quality control standards throughout the cell culture process
Optimized cell production for better yield, purity, and efficiency
Conducted quality control assessments during manufacturing to ensure compliance with regulatory standards
Updated and maintained SOPs, aligning with GMP regulations
Led the execution of manufacturing batches, managing bioreactors and other essential equipment operations
Addressed and resolved process deviations and equipment malfunctions to maintain production continuity
Maintained and increased CHO cells for production needs; review manufacturing records and SOPs
Entrusted with the overall accountability of administering the quality management systems, documenting the deviations, deploying the change controls, and generating the codes for new materials
Inoculated CHO cells and managed growth in 250mL and 500mL shake flasks; scaled processes to 50L and 500L bioreactors
Monitored cell growth using Vi-cell Metaflex, pH meters, osmometers, and Vi-cell XR analyzers
Conducted product harvesting and filtration with a 3M system; verified filter integrity
Prepared formulation buffers and sampled water for injection (WFI) for manufacturing use
Collaborated with R&D to scale benchtop processes to manufacturing levels, refining techniques for increased scalability
Coordinated with interdisciplinary teams to ensure consistency in achieving project goals and adherence to timelines
Explored and implemented new technologies to enhance manufacturing processes and product integrity.
R and D Scientist
Trivitron Healthcare (LabSystems Diagnostix in Europe)
, INDIA
02.2024 - 10.2024
Enzyme production and Oligo synthesis for R and D division under HOD guidance (situated on Finland)
Spearheaded the establishment of enzyme and oligo synthesis laboratories to support the development of DNA test kits for European markets
Setting up the R and D labs (Enzyme (using DH5-a E.coli) and Oligo synthesis labs) for a new division for IVD kits( to be sold in European markets)
Leading the projects for R and D in developing DNA test kits and optimization (Probes/Primers/Enzymes)
Structuring of the lab and other systems like SOPs, documentations
Production of Reverse Transcriptase and DNA polymerase using Biorad NGC and transformed DH5-a E.coli (Protein fractionation process)
Comparing the In-house synthesized enzymes with market giants
Execute oligo and Enzyme research in support of research goals, plans and supervisor input
Produce Oligos (Primers and Probes with different dyes), QC using Agilent Infinity 2 HPLC and Enzymes
Evaluate performance of the synthetic oligos and enzymes, QC using qPCR on Quant studio 5, Optimization
Engage in collaboration and interaction with team and partners to facilitate the development, characterization, and testing for project advancement
Lab Systems Diagnostics in Finland
Education
Master of Science - Biotechnology
Harrisburg University
05-2023
Masters - Biotechnology
Kean University
New Jersey, USA
05-2018
Skills
SOP Development
Lab Management
Microbiology & CAR-T
Research Management
Project Management
GMP & Aseptic Laboratory Techniques & Equipment
Quality Assurance
Cell Line Maintenance
Client Engagement
Team Management
GLP
GMP
Upstream processing
Excellent Aseptic Techniques
Making the Cells Competent
Cell Culture
MS Office
ELN
Write SOPs under the project head's guidance
Extensive work in BSL-2 Lab
Anaerobic chamber (AS-580)
Work on Cell imager (Quantom-M50)
Cell flow cytometer (Beckman Coulter and BD Lyric)
Developed protocol for bacterial transformations
Interpret and summarize experimental data
Maintained Bacterial cell cultures
Plasmid DNA cloning
Plasmid Purification
Performed ELISA
RT-PCR (Quant Studio 6)
Autoclave and waste disposal
Documenting the results (ELN-Biovia)
Maintaining laboratory equipment
Maintaining cancer cell lines
Laboratory maintenance
Inventory
Purchasing
Reagent preparation
Editing Bacterial Genome (CSIPR/CAS)
Strain archiving
DNA extraction
Spectrophotometers
Preparation of LB, MS, CRA, TKB, TSC and various other mediums
Genomic DNA isolation from Bacterial cells
Invasion Assays
Cell line maintenance
Autoclave operations
MerMade 192E Oligo synthesizer
HPLC/MS
K and H Oligo synthesizer
BioRad NGC chromatograph
Quant studio 5/7
Maintaining laboratory records
Sonication
SDS-PAGE
Western Blot
ELISA
RT-PCR
Techniques involving Induction and cloning of cell
Kean University, New Jersey, New Jersey, USA, (01/01/18 to 06/30/18), Transformation of Bacillus strain using CRISPR/Cas genome editing technology and development of an in-house electroporation protocol., The project involved genetic manipulation/transformation of Bacillus subtilis and E.coli using CRISPR/Cas9. Plasmid extraction using a Mini-prep kit. Plasmid with the target genes was introduced to the target organism using electroporation and then cloned. Designed protocols for bacterial transformations.
ATCC-CTM, New Jersey, New Jersey, USA,(05/01/17 to 09/30/17), Stimulation of Shigella Flexineri surface in the presence of bile salts at different concentrations., The project involved studying the stimulation of Shigella Flexineri in the presence of different bile salts at different concentrations on MDCK cells. It involved cell passaging, Assay plating and thawing. Invasion assays were also performed.
References:
ILSE Vice President - Dr. Robert McLaughlin, rmclaughlin@ilsebio.com
Eurofins Manager- Benjamin Bramble, email ID- BenjaminBramble@eurofinsus.com
Kashiv Bio Manager- Thomas Bednarz, email ID- thomasbednarz@yahoo.com
Trivitron/Lab SystemsDx Head of Deparment- Dr. Kevin Eboigbodin, email ID kevin.eboigbodin@labsystemsdx.com
Timeline
R and D Scientist
Trivitron Healthcare (LabSystems Diagnostix in Europe)
02.2024 - 10.2024
Upstream Manufacturing Scientist
Unicon Pharma (Client: Kashiv BioSciences)
08.2022 - 05.2023
CAR-T Scientist
Eurofins PSS (Client: Johnson & Johnson)
01.2020 - 08.2021
Sr. Research Associate
Institute for Life Sciences Entrepreneurship (ILSE)
08.2019 - 12.2019
Research Associate
Institute for Life Sciences Entrepreneurship (ILSE)